3544-24-9
3544-24-9 結構式
基本信息
間氨基苯甲酰胺
3-氯基苯甲酰胺
3-氨基苯丙酰胺98%
3-氨基苯甲酰胺,98%
3-AMINOBENZAMIDE
M-AMINOBENZAMIDE
3-amino-benzamid
Benzamide, 3-amino-
Benzamide, m-amino-
m-amino-benzamid
3-AB
m-Amino Benzamide 3-Amino Benzamide
Benzamide, 3-amino- (9CI)
3-Aminobenzamide,98%
META-AMINOBENZAMIDE
3-AB, 3-ABA
物理化學性質(zhì)
安全數(shù)據(jù)
3544-24-9(安全特性,毒性,儲運)
知名試劑公司產(chǎn)品信息
3-Aminobenzamide, 98%(3544-24-9)
3-Aminobenzamide,>98.0%(T)(3544-24-9)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2025/02/08 | HY-15045 | 3-氨基苯甲酰胺 INO-1001 | 3544-24-9 | 5mg | 970元 |
| 2025/02/08 | HY-15045 | 3-氨基苯甲酰胺 INO-1001 | 3544-24-9 | 10mM * 1mLin DMSO | 1070元 |
| 2025/02/08 | HY-15045 | 3-氨基苯甲酰胺 INO-1001 | 3544-24-9 | 10mg | 1700元 |
常見問題列表
| Target | Value |
|
PARP
() |
3-Aminobenzamide (PARP-IN-1) (>1 μM) causes more than 95% inhibition of PARP activity without significant cellular toxicity. INO-1001 significantly sensitizes CHO cells by blocking most of the DNA repair occurring between radiation fractions.?3-Aminobenzamide significantly improves endothelial function by enhancing the acetylcholine-induced, endothelium-dependent, nitric oxide mediated vasorelaxation after exposure with 400 μM H 2 O 2 .
In a db/db (Lepr db/db ) mouse model, 3-Aminobenzamide ameliorates diabetes-induced albumin excretion and mesangial expansion, and also decreases diabetes-induced podocyte depletion. 3-Aminobenzamide (1.6 mg/kg via intracerebral injection) prevents NAD + depletion and improves water maze performance after controlled cortical impact (CCI) in mice.